首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   56762篇
  免费   4027篇
  国内免费   135篇
  2021年   378篇
  2020年   341篇
  2019年   366篇
  2018年   899篇
  2017年   867篇
  2016年   1327篇
  2015年   2015篇
  2014年   2191篇
  2013年   2796篇
  2012年   3447篇
  2011年   3248篇
  2010年   1994篇
  2009年   1514篇
  2008年   2685篇
  2007年   2699篇
  2006年   2624篇
  2005年   2503篇
  2004年   2414篇
  2003年   2247篇
  2002年   2242篇
  2001年   1668篇
  2000年   1805篇
  1999年   1381篇
  1998年   529篇
  1997年   440篇
  1996年   408篇
  1995年   383篇
  1994年   396篇
  1993年   360篇
  1992年   858篇
  1991年   842篇
  1990年   811篇
  1989年   732篇
  1988年   712篇
  1987年   627篇
  1986年   617篇
  1985年   578篇
  1984年   520篇
  1983年   465篇
  1982年   418篇
  1981年   395篇
  1979年   522篇
  1978年   383篇
  1977年   341篇
  1975年   405篇
  1974年   379篇
  1973年   358篇
  1972年   386篇
  1971年   344篇
  1968年   334篇
排序方式: 共有10000条查询结果,搜索用时 328 毫秒
71.
72.
W Schlegel  S Krüger  K Korte 《FEBS letters》1984,171(1):141-144
Prostaglandin E2-9- oxoreductase (PGE2-9-OR), the enzyme which converts prostaglandin E2 (PGE2) to prostaglandin F2 alpha (PGF2 alpha), has been detected in human decidua vera. A 105-fold purification was achieved when the centrifuged homogenate was fractionated sequentially by DEAE-Trisacryl, hydroxyapatite-agarose gel, ultrogel AcA 44 and Matrex gel blue A gel chromatographies. The following kinetic constants for PGE2-9-OR have been obtained. The equilibrium constant with respect to PGE2 is 83 microM, the Michaelis constant, Km, for PGE2 is 80 microM, for NADPH 1.6 microM. The maximal velocity for the forward reaction is V1 = .203 pmol/min. The enzyme was inhibited by progesterone, oestradiol-17 beta, cortisol and pharmaceutical drugs. An activating effect could be demonstrated with Ca2+ and oxytocin. The occurrence of PGE2-9-OR in the decidua vera suggests that this enzyme may be responsible for the transformation of PGE2 to PGF2 alpha in these tissues. This may be an important mechanism for the initiation and maintenance of uterine contractions.  相似文献   
73.
74.
75.
Biomechanics and Modeling in Mechanobiology - The goal of this work is to assess the impact of vascular anatomy definition degree in the predictions of blood flow models of the arterial network. To...  相似文献   
76.
The metabolism of leukotrienes (B4, C4, D4, and E4) within human plasma was studied and a simple sample preparation is presented. It was demonstrated that leukotriene E4 and leukotriene B4 were stable during incubation at 37 degrees C using the in vitro system. In contrast, leukotriene C4 was metabolized by gamma-glutamyl transpeptidase activities into leukotriene D4 which was further metabolized by dipeptidase activities of plasma into leukotriene E4. The transition state inhibitor of gamma-glutamyl transpeptidase L-serine-borate decreased the metabolism of leukotriene C4 in plasma. Dilution of plasma demonstrated that the dipeptidase was more active compared to the gamma-glutamyl transpeptidase. The metabolizing activities of plasma were functionally characterized by fractionating the plasma proteins.  相似文献   
77.
78.
79.
80.
Pseudomonas sp. CBS3 was grown with 4-chlorobenzoate as sole source of carbon and energy. Freshly prepared cell-free extracts converted 4-chlorobenzoate to 4-hydroxybenzoate. After storage for 16 hours at 25 degrees C only about 50% of the initial activity was left. Treatment at 55 degrees C for 10 minutes, dialysis or desalting of the extracts by gel filtration caused a total loss of the activity of the 4-chlorobenzoate dehalogenase. The activity could be restored by the addition of ATP, coenzyme A and Mg2+. If one of these cofactors was missing, no dehalogenating activity was detectable. The amount of 4-hydroxybenzoate formed was proportional to the amount of ATP available in the test system whereas CoA served as a real coenzyme. A novel ATP/coenzyme A dependent reaction mechanism for the dehalogenation of 4-chlorobenzoate by 4-chlorobenzoate dehalogenase from Pseudomonas sp. CBS3 is proposed.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号